By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

DOR BioPharma, Inc. 

1101 Brickell Avenue
Suite 701 South
Miami  Florida  33131  U.S.A.
Phone: 786-425-3848 Fax: 786-425-3853


SEARCH JOBS








Company News
DOR BioPharma, Inc. (DORB) Announces Corporate Name Change to Soligenix and Begins Trading Under New Ticker Symbol 'SGNX' 9/30/2009 10:40:23 AM
DOR BioPharma, Inc. (DORB) Announces Private Equity Financing of $3.85 Million 9/24/2009 11:38:55 AM
DOR BioPharma, Inc. (DORB) Announces National Institutes of Health (NIH) Grant Award to Support Phase 1/2 Clinical Trial of DOR201 in Radiation Enteritis 9/8/2009 8:42:34 AM
DOR BioPharma, Inc. (DORB) Reports 2nd Quarter and 1st Half 2009 Financial Results and Reviews Recent Accomplishments 8/14/2009 8:18:25 AM
DOR BioPharma, Inc. (DORB) Announces Issuance of European Patent for its LPM(TM) Oral Drug Delivery Technology 7/8/2009 10:34:45 AM
DOR BioPharma, Inc. (DORB) Appoints Christopher P. Schnittker, CPA, as Vice President of Administration and Controller Company 7/7/2009 10:41:32 AM
DOR BioPharma, Inc. (DORB) Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD 6/9/2009 10:13:51 AM
DOR BioPharma, Inc. (DORB) Reports 1st Quarter 2009 Financial Results and Reviews Recent Accomplishments 5/15/2009 10:38:08 AM
DOR BioPharma, Inc. (DORB) Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments 3/31/2009 9:15:41 AM
DOR BioPharma, Inc. (DORB) Executes $400,000 Equity Investment Agreement With Numoda Corporation 3/25/2009 10:35:40 AM
12345678910...
//-->